Abstract
Hyperactivation of YAP/TAZ, the Hippo pathway downstream effectors, is common in human cancer. In this perspective, the authors review the role of the Hippo pathway in distinct tumor cell populations, discuss the impact of inhibiting Hippo output on tumor growth, and examine current developments in YAP/TAZ inhibitors.
Cite
CITATION STYLE
APA
Baroja, I., Kyriakidis, N. C., Halder, G., & Moya, I. M. (2024). Expected and unexpected effects after systemic inhibition of Hippo transcriptional output in cancer. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-46531-1
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free